Tarpeyo

NDC 81749-004 · Calliditas Therapeutics AB

Generic namebudesonide

Dosage formCAPSULE, DELAYED RELEASE

RouteORAL

Active ingredient(s)BUDESONIDE

Strength4 mg/1

Pharmacologic classCorticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]

Marketing categoryNDA

Packages

81749-004-01 — 120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01)

FDA lists these products with the same active ingredient.

68682-309 — budesonide, 68682-658 — budesonide, 68788-7314 — Budesonide, 68788-8429 — Budesonide, 68788-8503 — budesonide inhalation, 69097-318 — Budesonide, 69097-319 — Budesonide, 69097-321 — Budesonide, 69842-001 — Budesonide, 70518-4613 — budesonide, 70771-1075 — budesonide, 72162-2473 — budesonide, 76282-640 — Budesonide, 76282-641 — Budesonide, 76282-642 — Budesonide, 85612-010 — Budesonide, 85612-011 — Budesonide, 85766-113 — Budesonide and Formoterol Fumarate Dihydrate, 85766-114 — Budesonide and Formoterol Fumarate Dihydrate, 85766-184 — Budesonide and Formoterol Fumarate Dihydrate, +69 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.